Fig. 1From: The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic miceMorphology and multilineage differentiation of MSCs harvested from different tissue. A Representative micrographs of MSCs derived from umbilical cord Wharton’s jelly (UC), dental pulp (PU), and adipose (AD) observed under light microscopy. The MSCs appeared fibroblast-shaped. MSCs were able to differentiate into adipocytes identified by Oil Red O staining, osteocytes by Alizarin Red staining, and chondrocytes by Alcian blue staining. Scale bar = 50 μm. B Growth curves of MSCs and their cell viability. C–E Flow cytometric analysis of the expression of surface markers on MSCs. All three types of MSCs showed high expression of MSC-specific surface markers (CD105, CD73, CD90, or CD44), and low expression of hematopoietic cell marker (CD34), leucocyte marker (CD45), monocyte/macrophage marker (HLA-DR), or immune cell marker (CD31). Representative histograms of 3 independent experiments are shownBack to article page